{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:37:22Z","timestamp":1790102242497,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.7759\/cureus.48143","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T05:52:34Z","timestamp":1698904354000},"source":"Crossref","is-referenced-by-count":20,"title":["Genitourinary Syndrome of Menopause: A Narrative Review Focusing on Its Effects on the Sexual Health and Quality of Life of Women"],"prefix":"10.7759","author":[{"given":"Vaibhavi B","family":"Wasnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neema","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"21","author":"Portman DJ","year":"2014","unstructured":"Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014, 21:1063-8. 10.1097\/GME.0000000000000329","journal-title":"Menopause"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00561","article-title":"Addressing vulvovaginal atrophy (VVA)\/genitourinary syndrome of menopause (GSM) for healthy aging in women","volume":"10","author":"Nappi RE","year":"2019","unstructured":"Nappi RE, Martini E, Cucinella L, et al.. Addressing vulvovaginal atrophy (VVA)\/genitourinary syndrome of menopause (GSM) for healthy aging in women. Front Endocrinol (Lausanne). 2019, 10:561. 10.3389\/fendo.2019.00561","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2017.1421921","article-title":"Genitourinary syndrome of menopause: prevalence and quality of life in Spanish postmenopausal women the GENISSE study","volume":"21","author":"Moral E","year":"2018","unstructured":"Moral E, Delgado JL, Carmona F, et al.. Genitourinary syndrome of menopause: prevalence and quality of life in Spanish postmenopausal women the GENISSE study. Climacteric. 2018, 21:167-73. 10.1080\/13697137.2017.1421921","journal-title":"Climacteric"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.07.045","article-title":"Genitourinary syndrome of menopause: an\u00a0overview of clinical manifestations, pathophysiology, etiology, evaluation, and\u00a0management","volume":"215","author":"Gandhi J","year":"2016","unstructured":"Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an\u00a0overview of clinical manifestations, pathophysiology, etiology, evaluation, and\u00a0management. Am J Obstet Gynecol. 2016, 215:704-11. 10.1016\/j.ajog.2016.07.045","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000926","article-title":"Missing documentation in breast cancer survivors: genitourinary syndrome of menopause","volume":"24","author":"Cook ED","year":"2017","unstructured":"Cook ED, Iglehart EI, Baum G, Schover LL, Newman LL. Missing documentation in breast cancer survivors: genitourinary syndrome of menopause. Menopause. 2017, 24:1360-4. 10.1097\/GME.0000000000000926","journal-title":"Menopause"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/20.248","article-title":"What is genitourinary syndrome of menopause and why should we care?","volume":"25","author":"Peters KJ","year":"2021","unstructured":"Peters KJ. What is genitourinary syndrome of menopause and why should we care?. Perm J. 2021, 25:3-7. 10.7812\/TPP\/20.248","journal-title":"Perm J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.31729\/jnma.7237","article-title":"Genitourinary syndrome of menopause among postmenopausal women in a tertiary care centre: a descriptive cross-sectional study","volume":"60","author":"Ojha N","year":"2022","unstructured":"Ojha N, Bista KD, Bajracharya S, Katuwal N. Genitourinary syndrome of menopause among postmenopausal women in a tertiary care centre: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2022, 60:126-31. 10.31729\/jnma.7237","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.779398","article-title":"Genitourinary syndrome of menopause: Epidemiology, physiopathology, clinical manifestation and diagnostic","volume":"3","author":"Sarmento AC","year":"2021","unstructured":"Sarmento AC, Costa AP, Vieira-Baptista P, Giraldo PC, Eleut\u00e9rio J Jr, Gon\u00e7alves AK. Genitourinary syndrome of menopause: Epidemiology, physiopathology, clinical manifestation and diagnostic. Front Reprod Health. 2021, 3:779398. 10.3389\/frph.2021.779398","journal-title":"Front Reprod Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7586","article-title":"The genitourinary syndrome of menopause: an overview of the recent data","volume":"12","author":"Angelou K","year":"2020","unstructured":"Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020, 12:e7586. 10.7759\/cureus.7586","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2053369119884144","article-title":"Genitourinary syndrome of menopause","volume":"26","author":"Briggs P","year":"2020","unstructured":"Briggs P. Genitourinary syndrome of menopause. Post Reprod Health. 2020, 26:111-4. 10.1177\/2053369119884144","journal-title":"Post Reprod Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31805170eb","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society","volume":"14","year":"2007","unstructured":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women. 2007 position statement of The North American Menopause Society. Menopause. 2007, 14:355-69. 10.1097\/gme.0b013e31805170eb","journal-title":"Menopause"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride MB","year":"2010","unstructured":"Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010, 85:87-94. 10.4065\/mcp.2009.0413","journal-title":"Mayo Clin Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.23","article-title":"Are women with urogenital atrophy symptomatic?","volume":"188","author":"Davila GW","year":"2003","unstructured":"Davila GW, Singh A, Karapanagiotou I, et al.. Are women with urogenital atrophy symptomatic?. Am J Obstet Gynecol. 2003, 188:382-8. 10.1067\/mob.2003.23","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2015.09.001","article-title":"Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study","volume":"83","author":"Palma F","year":"2016","unstructured":"Palma F, Volpe A, Villa P, Cagnacci A. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas. 2016, 83:40-4. 10.1016\/j.maturitas.2015.09.001","journal-title":"Maturitas"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.6118\/jmm.2015.21.2.65","article-title":"The recent review of the genitourinary syndrome of menopause","volume":"21","author":"Kim HK","year":"2015","unstructured":"Kim HK, Kang SY, Chung YJ, Kim JH, Kim MR. The recent review of the genitourinary syndrome of menopause. J Menopausal Med. 2015, 21:65-71. 10.6118\/jmm.2015.21.2.65","journal-title":"J Menopausal Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal health: insights, views & attitudes (VIVA) - results from an international survey","volume":"15","author":"Nappi RE","year":"2012","unstructured":"Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) - results from an international survey. Climacteric. 2012, 15:36-44. 10.3109\/13697137.2011.647840","journal-title":"Climacteric"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31815a5168","article-title":"Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women","volume":"15","author":"Levine KB","year":"2008","unstructured":"Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause. 2008, 15:661-6. 10.1097\/gme.0b013e31815a5168","journal-title":"Menopause"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(03)00676-9","article-title":"The role of estrogens in female lower urinary tract dysfunction","volume":"62","author":"Robinson D","year":"2003","unstructured":"Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology. 2003, 62:45-51. 10.1016\/s0090-4295(03)00676-9","journal-title":"Urology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2016.09.001","article-title":"What is the real impact of urinary incontinence on female sexual dysfunction? A case control study","volume":"5","author":"Felippe MR","year":"2017","unstructured":"Felippe MR, Zambon JP, Girotti ME, Burti JS, Hacad CR, Cadamuro L, Almeida F. What is the real impact of urinary incontinence on female sexual dysfunction? A case control study. Sex Med. 2017, 5:e54-60. 10.1016\/j.esxm.2016.09.001","journal-title":"Sex Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2015.05.009","article-title":"Menopause and sexuality","volume":"44","author":"Thornton K","year":"2015","unstructured":"Thornton K, Chervenak J, Neal-Perry G. Menopause and sexuality. Endocrinol Metab Clin North Am. 2015, 44:649-61. 10.1016\/j.ecl.2015.05.009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12235","article-title":"The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners","volume":"10","author":"Nappi RE","year":"2013","unstructured":"Nappi RE, Kingsberg S, Maamari R, Simon J. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med. 2013, 10:2232-41. 10.1111\/jsm.12235","journal-title":"J Sex Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12190","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey","volume":"10","author":"Kingsberg SA","year":"2013","unstructured":"Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med. 2013, 10:1790-9. 10.1111\/jsm.12190","journal-title":"J Sex Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfpn.2021.01.004","article-title":"Genitourinary syndrome of menopause: screening and treatment","volume":"3","author":"Henry-Okafor Q","year":"2021","unstructured":"Henry-Okafor Q, DeBruyn E, Ott M, Moore G. Genitourinary syndrome of menopause: screening and treatment. Adv Fam Pract Nurs. 2021, 3:111-9. 10.1016\/j.yfpn.2021.01.004","journal-title":"Adv Fam Pract Nurs"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2019.1600499","article-title":"Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy","volume":"22","author":"Palacios S","year":"2019","unstructured":"Palacios S. Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy. Climacteric. 2019, 22:348-51. 10.1080\/13697137.2019.1600499","journal-title":"Climacteric"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2015.1079100","article-title":"Treatment of the genitourinary syndrome of menopause","volume":"18","author":"Palacios S","year":"2015","unstructured":"Palacios S, Mej\u00eda A, Neyro JL. Treatment of the genitourinary syndrome of menopause. Climacteric. 2015, 18:23-9. 10.3109\/13697137.2015.1079100","journal-title":"Climacteric"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2217\/17455057.1.2.279","article-title":"Treating urogenital atrophy","volume":"1","author":"Brown C","year":"2005","unstructured":"Brown C, Bachman G. Treating urogenital atrophy. Womens Health (Lond). 2005, 1:279-92. 10.2217\/17455057.1.2.279","journal-title":"Womens Health (Lond)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)56474-7","article-title":"Comparative study: Replens versus local estrogen in menopausal women","volume":"61","author":"Nachtigall LE","year":"1994","unstructured":"Nachtigall LE. Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril. 1994, 61:178-80. 10.1016\/s0015-0282(16)56474-7","journal-title":"Fertil Steril"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10081528","article-title":"Hyaluronic acid: a valid therapeutic option for early management of genitourinary syndrome of menopause in cancer survivors?","volume":"10","author":"Nappi RE","year":"2022","unstructured":"Nappi RE, Martella S, Albani F, Cassani C, Martini E, Landoni F. Hyaluronic acid: a valid therapeutic option for early management of genitourinary syndrome of menopause in cancer survivors?. Healthcare (Basel). 2022, 10:1-5. 10.3390\/healthcare10081528","journal-title":"Healthcare (Basel)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2012.756466","article-title":"Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview","volume":"16","author":"Sinha A","year":"2013","unstructured":"Sinha A, Ewies AA. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric. 2013, 16:305-12. 10.3109\/13697137.2012.756466","journal-title":"Climacteric"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.781353","article-title":"Use of moisturizers and lubricants for vulvovaginal atrophy","volume":"3","author":"Sarmento AC","year":"2021","unstructured":"Sarmento AC, Kamilos MF, Costa AP, Vieira-Baptista P, Eleut\u00e9rio J Jr, Gon\u00e7alves AK. Use of moisturizers and lubricants for vulvovaginal atrophy. Front Reprod Health. 2021, 3:781353. 10.3389\/frph.2021.781353","journal-title":"Front Reprod Health"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001609","article-title":"The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society","volume":"27","year":"2020","unstructured":"The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020, 27.976-92. 10.1097\/GME.0000000000001609","journal-title":"Menopause"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001500.pub2","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"4","author":"Suckling J","year":"2006","unstructured":"Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006, 4:CD001500. 10.1002\/14651858.CD001500.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy","volume":"13","author":"Sturdee DW","year":"2010","unstructured":"Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010, 13:509-22. 10.3109\/13697137.2010.522875","journal-title":"Climacteric"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2017.1281083","article-title":"The evolving role of oral hormonal therapies and review of conjugated estrogens\/bazedoxifene for the management of menopausal symptoms","volume":"129","author":"Parish SJ","year":"2017","unstructured":"Parish SJ, Gillespie JA. The evolving role of oral hormonal therapies and review of conjugated estrogens\/bazedoxifene for the management of menopausal symptoms. Postgrad Med. 2017, 129:340-51. 10.1080\/00325481.2017.1281083","journal-title":"Postgrad Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00700-w","article-title":"Practical treatment considerations in the management of genitourinary syndrome of menopause","volume":"36","author":"Kagan R","year":"2019","unstructured":"Kagan R, Kellogg-Spadt S, Parish SJ. Practical treatment considerations in the management of genitourinary syndrome of menopause. Drugs Aging. 2019, 36:897-908. 10.1007\/s40266-019-00700-w","journal-title":"Drugs Aging"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2008.06.003","article-title":"Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women","volume":"111","author":"Labrie F","year":"2008","unstructured":"Labrie F, Cusan L, Gomez JL, et al.. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. J Steroid Biochem Mol Biol. 2008, 111:178-94. 10.1016\/j.jsbmb.2008.06.003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society","volume":"20","year":"2013","unstructured":"Management of symptomatic vulvovaginal atrophy. 2013 position statement of The North American Menopause Society. Menopause. 2013, 20:888-902. 10.1097\/GME.0b013e3182a122c2","journal-title":"Menopause"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58060770","article-title":"New innovations for the treatment of vulvovaginal atrophy: an up-to-date review","volume":"58","author":"Benini V","year":"2022","unstructured":"Benini V, Ruffolo AF, Casiraghi A, et al.. New innovations for the treatment of vulvovaginal atrophy: an up-to-date review. Medicina (Kaunas). 2022, 58:3-7. 10.3390\/medicina58060770","journal-title":"Medicina (Kaunas)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184094-genitourinary-syndrome-of-menopause-a-narrative-review-focusing-on-its-effects-on-the-sexual-health-and-quality-of-life-of-women","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:08:41Z","timestamp":1707491321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184094-genitourinary-syndrome-of-menopause-a-narrative-review-focusing-on-its-effects-on-the-sexual-health-and-quality-of-life-of-women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.48143","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,2]]}}}